comparemela.com

Latest Breaking News On - Investigational use - Page 5 : comparemela.com

World-Renowned Cardiologists and Cardiac Surgeons to Feature Innovative Heart Failure Therapies at Technology and Heart Failure Therapeutics, March 20-22, 2023

/PRNewswire/ WHAT: Innovative therapeutic approaches for left ventricular restoration for patients with Heart Failure with Reduced Ejection Fraction (HFrEF)..

United statesOri ben yehuda bioventrix incInvestigational useMichael pfeiffer penn state hershey medical centerBioventrix incHeart failureReduced ejection fractionLeft ventricularLess invasive ventricular enhancementBioventrix reviventTranscatheter ventricular enhancementBoston seaport districtCardiac surgeonsGuideline directed medical therapyLeft ventricleInterventional heart failure

New Study Demonstrates Accurate Measurement of Left Ventricular Function Following Treatment with BioVentrix Revivent TC® Therapy

/PRNewswire/ BioVentrix®, Inc., a privately held medical device company developing less invasive therapies to directly treat the dilated left ventricle.

United statesInvestigational useBioventrix incDrug administrationAccess programInward displacement approach assessesLeft ventricular deviceClinical medicineInward displacementNovel approachMeasuring left ventricularUndergoing bioventrixBioventrix reviventRishi puriStructural interventional cardiologistCleveland clinic

New contactless health monitoring technology Anura™ enables mobile carriers and handset developers to integrate digital health solution

/CNW/ - NuraLogix, a global pioneer of contactless health monitoring showcases a host of new capabilities of its Anura™ platform at MWC 2023. Using mobile and.

United statesComunidad autonoma de catalunaKeith thompsonAnxiety health riskMental healthPhysiological health vitals indexesNuralogix corporationMental health risk assessmentsPhysiological health risk assessmentsDepression health riskBupa groupTransdermal optical imagingRemote photoplethysmographyCardiovascular diseaseFasting blood glucoseChief medical officer

NuraLogix Corporation: New contactless health monitoring technology Anura enables mobile carriers and handset developers to integrate digital health solution

New contactless health monitoring technology Anura enables mobile carriers and handset developers to integrate digital health solution PR Newswire BARCELONA, Spain, Feb. 26, 2023

United statesComunidad autonoma de catalunaDennis riedlKeith thompsonAnxiety health riskMental healthPhysiological health vitals indexesMental health risk assessmentsPhysiological health risk assessmentsDepression health riskAnura softwareBupa groupTransdermal optical imagingRemote photoplethysmographyCardiovascular diseaseFasting blood glucose

BioVentrix® Names Dr Ori Ben-Yehuda as Chief Medical Officer

/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated.

United statesSan diegoJim dillonUniversity of californiaInvestigational useGilead sciencesDrug administrationJournal of the heart teamPatient care experience to senior management teamBioventrix incDepartment of medicine teachingClinical trials centerCardiovascular research foundationAccess programBrings extensive clinical trialPatient care experience

vimarsana © 2020. All Rights Reserved.